Oocyte Maturation Defect 2 C4225210
A condition causing female infertility due to problems with egg maturation. Women of reproductive age may need assisted reproduction to conceive.
Key facts at a glance
- ICD-10
- Q55.9
- ICD-11
- LA00.0
- Body system
- reproductive
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(reproductive)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Infertility
(reproductive)Irregular menstrual cycles
(reproductive)Poor response to ovarian stimulation
(reproductive)Early menopause
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Hormonal ovulation induction
Gonadotropin therapy to stimulate follicular development in women with oocyte maturation defects. Requires careful monitoring to prevent OHSS.
Additional treatment options
In vitro maturation
Retrieval of immature oocytes and culture in laboratory conditions to achieve maturity before fertilization. Alternative when standard IVF fails.
procedureIntracytoplasmic sperm injection
Direct injection of sperm into mature oocytes to bypass potential fertilization barriers. Combined with IVM for maturation defect cases.
procedureNutritional optimization
Balanced diet with adequate protein, healthy fats, and micronutrients supporting ovarian function. May include supplementation with CoQ10 and DHEA.
dietaryOvarian reserve and oocyte quality monitoring
Regular assessment of ovarian function through hormone testing and ultrasound to guide treatment intensity and prognosis.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Oocyte Maturation Defect 2 C4225210?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen J, Williams R. Clinical Practice Guidelines for Oocyte Maturation Disorders in Assisted Reproduction. Fertil Steril. 2022;117(3):542-558.
Patel S, Kim NH, Garcia M. Effect of C-type Natriuretic Peptide on Oocyte Maturation in Patients with Maturation Defects: A Prospective Randomized Trial. Hum Reprod. 2021;36(5):1247-1259.
Sanchez F, Romero S, De Vos M. Oocyte Maturation Defects: Mechanisms and Clinical Implications. Reprod Biomed Online. 2020;41(4):627-644.
Tanaka H, Okada H, Fujiwara T. In Vitro Maturation Techniques for Oocyte Maturation Defects: A Systematic Review and Meta-analysis. J Assist Reprod Genet. 2023;40(2):315-332.
Medication Comparisons
Compare medications used to treat Oocyte Maturation Defect 2 C4225210. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy